Carregant...
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma
RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...
Guardat en:
| Publicat a: | Cell Cycle |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/ https://ncbi.nlm.nih.gov/pubmed/33064970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|